BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30444251)

  • 1. Targeting small molecule drugs to T cells with antibody-directed cell-penetrating gold nanoparticles.
    Yang YS; Moynihan KD; Bekdemir A; Dichwalkar TM; Noh MM; Watson N; Melo M; Ingram J; Suh H; Ploegh H; Stellacci FR; Irvine DJ
    Biomater Sci; 2018 Dec; 7(1):113-124. PubMed ID: 30444251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors.
    Zheng Y; Tang L; Mabardi L; Kumari S; Irvine DJ
    ACS Nano; 2017 Mar; 11(3):3089-3100. PubMed ID: 28231431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing radiotherapy by lipid nanocapsule-mediated delivery of amphiphilic gold nanoparticles to intracellular membranes.
    Yang YS; Carney RP; Stellacci F; Irvine DJ
    ACS Nano; 2014 Sep; 8(9):8992-9002. PubMed ID: 25123510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells.
    Yi Y; Kim HJ; Zheng M; Mi P; Naito M; Kim BS; Min HS; Hayashi K; Perche F; Toh K; Liu X; Mochida Y; Kinoh H; Cabral H; Miyata K; Kataoka K
    J Control Release; 2019 Feb; 295():268-277. PubMed ID: 30639386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced intracellular translocation and biodistribution of gold nanoparticles functionalized with a cell-penetrating peptide (VG-21) from vesicular stomatitis virus.
    Tiwari PM; Eroglu E; Bawage SS; Vig K; Miller ME; Pillai S; Dennis VA; Singh SR
    Biomaterials; 2014 Nov; 35(35):9484-94. PubMed ID: 25154664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
    Patra CR; Bhattacharya R; Wang E; Katarya A; Lau JS; Dutta S; Muders M; Wang S; Buhrow SA; Safgren SL; Yaszemski MJ; Reid JM; Ames MM; Mukherjee P; Mukhopadhyay D
    Cancer Res; 2008 Mar; 68(6):1970-8. PubMed ID: 18339879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bisphosphonate ligands and PEGylation on targeted delivery of gold nanoparticles for contrast-enhanced radiographic detection of breast microcalcifications.
    Cole LE; McGinnity TL; Irimata LE; Vargo-Gogola T; Roeder RK
    Acta Biomater; 2018 Dec; 82():122-132. PubMed ID: 30316022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation.
    Mottas I; Bekdemir A; Cereghetti A; Spagnuolo L; Yang YS; Müller M; Irvine DJ; Stellacci F; Bourquin C
    Biomaterials; 2019 Jan; 190-191():111-120. PubMed ID: 30415018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
    Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
    Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
    Revia RA; Stephen ZR; Zhang M
    Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-Sensitive Polymeric Nanoparticles with Gold(I) Compound Payloads Synergistically Induce Cancer Cell Death through Modulation of Autophagy.
    Lin YX; Gao YJ; Wang Y; Qiao ZY; Fan G; Qiao SL; Zhang RX; Wang L; Wang H
    Mol Pharm; 2015 Aug; 12(8):2869-78. PubMed ID: 26101892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ImmunoPET Imaging of Pancreatic Tumors with
    Sobol NB; Korsen JA; Younes A; Edwards KJ; Lewis JS
    Mol Imaging Biol; 2021 Feb; 23(1):84-94. PubMed ID: 32909244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold Nanoparticles Coimmobilized with Small Molecule Toll-Like Receptor 7 Ligand and α-Mannose as Adjuvants.
    Shinchi H; Yamaguchi T; Moroishi T; Yuki M; Wakao M; Cottam HB; Hayashi T; Carson DA; Suda Y
    Bioconjug Chem; 2019 Nov; 30(11):2811-2821. PubMed ID: 31560198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of small molecules and drug delivery applications using gold and iron nanoparticles.
    Jahangirian H; Kalantari K; Izadiyan Z; Rafiee-Moghaddam R; Shameli K; Webster TJ
    Int J Nanomedicine; 2019; 14():1633-1657. PubMed ID: 30880970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine induced killer cells-assisted delivery of chlorin e6 mediated self-assembled gold nanoclusters to tumors for imaging and immuno-photodynamic therapy.
    Xia F; Hou W; Liu Y; Wang W; Han Y; Yang M; Zhi X; Li C; Qi D; Li T; Martinez de la Fuente J; Zhang C; Song J; Cui D
    Biomaterials; 2018 Jul; 170():1-11. PubMed ID: 29635107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-Penetrating Nanoparticles Activate the Inflammasome to Enhance Antibody Production by Targeting Microtubule-Associated Protein 1-Light Chain 3 for Degradation.
    Zhu M; Du L; Zhao R; Wang HY; Zhao Y; Nie G; Wang RF
    ACS Nano; 2020 Mar; 14(3):3703-3717. PubMed ID: 32057231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting dendritic cells through gold nanoparticles: A review on the cellular uptake and subsequent immunological properties.
    Ahmad S; Zamry AA; Tan HT; Wong KK; Lim J; Mohamud R
    Mol Immunol; 2017 Nov; 91():123-133. PubMed ID: 28898717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
    Zhou J; Chen J; Zhong R; Mokotoff M; Shultz LD; Ball ED
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2224-31. PubMed ID: 16609038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy.
    Jiang J; Zhang Y; Peng K; Wang Q; Hong X; Li H; Fan G; Zhang Z; Gong T; Sun X
    Acta Biomater; 2017 Oct; 61():114-123. PubMed ID: 28483693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.